We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$51.4B
AUM Growth
+$13.1B
Cap. Flow
+$8.75B
Cap. Flow %
17.03%
Top 10 Hldgs %
11.55%
Holding
4,952
New
890
Increased
1,581
Reduced
1,213
Closed
646

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$320M
2
BAC icon
Bank of America
BAC
+$258M
3
KO icon
Coca-Cola
KO
+$215M
4
UNP icon
Union Pacific
UNP
+$215M
5
CSCO icon
Cisco
CSCO
+$214M

Sector Composition

Rank Sector Weight
1 Technology 17.06%
2 Consumer Discretionary 11.45%
3 Healthcare 11.42%
4 Financials 9.96%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCON
4001
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$140 ﹤0.01%
+40
New +$141
AXDX
4002
DELISTED
Accelerate Diagnostics
AXDX
$137 ﹤0.01%
35
TENX icon
4003
Tenax Therapeutics
TENX
$424M
$137 ﹤0.01%
+6
New +$144
MSC
4004
Studio City International Holdings
MSC
$370M
$136 ﹤0.01%
21
BIOR
4005
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$135 ﹤0.01%
+10
New +$162
CCGWW
4006
Cheche Group Inc Warrant
CCGWW
$256K
$134 ﹤0.01%
2,400
GMBL
4007
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$134 ﹤0.01%
34
+33
+3,300% +$610
XYF
4008
X Financial
XYF
$189M
$132 ﹤0.01%
36
ARQ icon
4009
Arq
ARQ
$84.1M
$128 ﹤0.01%
43
EXI icon
4010
iShares Global Industrials ETF
EXI
$1.41B
$127 ﹤0.01%
+1
New +$117
IDEV icon
4011
iShares Core MSCI International Developed Markets ETF
IDEV
$31.1B
$127 ﹤0.01%
2
-486
-100% -$29K
HIND
4012
Vyome Holdings
HIND
$14M
0
ICD
4013
DELISTED
Independence Contract Drilling, Inc.
ICD
$123 ﹤0.01%
50
KARO icon
4014
Karooooo
KARO
$1.97B
$122 ﹤0.01%
5
RGC icon
4015
Regencell Bioscience
RGC
$2.75B
$122 ﹤0.01%
494
ASLN
4016
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$122 ﹤0.01%
29
FBIZ icon
4017
First Business Financial Services
FBIZ
$568M
$120 ﹤0.01%
3
TPST icon
4018
Tempest Therapeutics
TPST
$14.8M
$119 ﹤0.01%
2
EVO icon
4019
Evotec
EVO
$703M
$117 ﹤0.01%
10
PRPH
4020
DELISTED
ProPhase Labs
PRPH
$113 ﹤0.01%
3
TCRT icon
4021
Alaunos Therapeutics
TCRT
$4.71M
$112 ﹤0.01%
11
-1
-8% -$12
HUDI icon
4022
Huadi International Group
HUDI
$11.1M
$106 ﹤0.01%
35
LUXE
4023
LuxExperience B.V.
LUXE
$1.15B
$102 ﹤0.01%
32
-2,832
-99% -$8.82K
MHH icon
4024
Mastech Digital
MHH
$93.1M
$101 ﹤0.01%
12
STRT icon
4025
STRATTEC Security
STRT
$368M
$100 ﹤0.01%
4

Similar funds

Qube Research & Technologies (QRT)'s Q4 2023 Portfolio in Review

As of Q4 2023, Qube Research & Technologies (QRT) held 4,952 positions worth $51.4B, up 34% from $38.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Qube Research & Technologies (QRT) deployed $8.75B of net new capital in Q4 2023, opening 890 new positions and adding to 1,581 existing holdings. Its largest new stake was Walt Disney: 2,082,380 shares worth $188M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $320M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q4 2023 buy was Walt Disney: 2,082,380 shares worth $188M.
  • Qube Research & Technologies (QRT) added most to UnitedHealth in Q4 2023, an estimated $336M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2023 reduction was McDonald's, cutting an estimated $320M.
  • Qube Research & Technologies (QRT) fully exited Activision Blizzard in Q4 2023, selling an estimated $131M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 12% of its $51.4B portfolio in Q4 2023.
  • Qube Research & Technologies (QRT) opened 890 new positions and closed 646 in Q4 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 34% quarter-over-quarter to $51.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.